CoChat

Sertraline for Major Depression in Children and Adolescents: Preliminary Clinical Experience

TIERNEY, ELAINE, JOSHI, PARAMJIT T., LLINAS, JOSEPH F., ROSENBERG, LEON A., RIDDLE, MARK A. · 1995 · Journal of Child and Adolescent Psychopharmacology
Cited by 52

The DOI matches its Crossref record.

Abstract

Objective: To evaluate the therapeutic and adverse effects of sertraline in children and adolescents with major depressive disorder (MDD). Method: Retrospective chart reviews were conducted on 33 youths (ages 8–18 years) treated for MDD with sertraline and no other psychotropic medication. Focusing on the interval from 2 to 10 weeks of treatment (when therapeutic changes were anticipated), clinical changes were assessed utilizing the Clinical Global Impression (CGI) subscales for severity of illness (modified to reflect severity of depressive illness) in 21 patients and for global improvement in 17 patients. Adverse effects were assessed in all 33 patients. Results: By the tenth week of treatment, the mean scores for severity of depressive illness changed significantly from 5.8 to 3.4 (6 = severely ill, 3 = mildly ill) and global improvement scores indicated that 11 of 17 patients (65%) improved much or very much. Older children improved to a greater degree. Mean dose was 1.6 mg/kg or 100 mg (range 25–200 mg) daily. No data were collected on which symptoms may have responded. Adverse effects were experienced by 16 of 33 patients, and 8 discontinued sertraline due to adverse effects. Seven patients (21%), including 4 of the 8 discontinuers, experienced behavioral side effects, whose onset clustered within the first 2 weeks and at 3 months of treatment. Two patients developed mania during sertraline treatment (one at 3 days, other at 94 days), and five developed other types of behavioral activation. No patient showed a worsening of depressive symptoms or an onset of suicidality or violence. Fatigue and sedation appeared to resolve spontaneously. Conclusion: These preliminary and uncontrolled clinical findings suggest that some children and adolescents with MDD may respond to sertraline, but adverse behavioral effects may be common.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.1995.5.13

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 52

Metadata

Authors
TIERNEY, E., JOSHI, P. T., LLINAS, J. F., ROSENBERG, L. A., & RIDDLE, M. A.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
1995-01
Volume
5
Issue
1
Pages
13-27
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2044864138
Cited by
52
References
0
FWCI
3.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sertraline for Major Depression in Children and Adolescents: Preliminary Clinical Experience. https://app.cochat.ai/papers/10.1089/cap.1995.5.13
The paper
TIERNEY, E., JOSHI, P. T., LLINAS, J. F., ROSENBERG, L. A., & RIDDLE, M. A. (1995). Sertraline for Major Depression in Children and Adolescents: Preliminary Clinical Experience. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.1995.5.13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.